Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 2

Natalizumab for the treatment of relapsing multiple sclerosis

Total article views   HTML views PDF downloads Totals
7,928 Dovepress* 7,928+ 2,546 10,474
Totals 7,928 2,546 10,474
*Since 6 June 2008
+Since July 2016

View citations on Google Scholar